ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,178,000 | +35.9% | 12,654 | -0.9% | 0.02% | +22.2% |
| Q2 2021 | $1,603,000 | -7.4% | 12,772 | +0.1% | 0.02% | -18.2% |
| Q1 2021 | $1,731,000 | +4.2% | 12,763 | -1.8% | 0.02% | +15.8% |
| Q4 2020 | $1,661,000 | -99.9% | 12,994 | +1.6% | 0.02% | -29.6% |
| Q3 2020 | $1,440,000,000 | – | 12,794 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
| Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
| Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
| Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
| QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
| Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
| Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
| SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
| Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |